Holder snapshot 7 signals
Share change
+4,016,941
Put/Call ratio
87%
SEC-reported price per share
$161.07
Number of holders
243
Value change
+$644,797,785
Number of buys
153
Open additional details 1 more signal available
Number of sells
92
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
62,650,155

Security key

78667J108

Report period

Q1 2018

Institutions

243

Top holders

10

Ownership snapshot

Top reported holders of SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PRICE T ROWE ASSOCIATES I...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
15/15
Latest evidence
31 Dec 2017
13F Lead comparable stake: 10% Showing 1-6 of 15 holder rows.

Quick read

PRICE T ROWE ASSOCIATES INC /MD/ leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Comparable ownership Top 5
PRICE T ROWE ASSOCIATES INC /MD/ 10%
FMR LLC 10%
BlackRock Finance, Inc. 5.5%
VANGUARD GROUP INC 5.4%
WELLINGTON MANAGEMENT GROUP LLP 3.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
10%
$1,039,537,000
6,311,317 shares
31 Dec 2017
FMR LLC
13F
Company
13F
10%
$1,027,381,000
6,237,519 shares
31 Dec 2017
BlackRock Finance, Inc.
13F
Company
13F
5.5%
$567,290,000
3,444,171 shares
31 Dec 2017
VANGUARD GROUP INC
13F
Company
13F
5.4%
$552,182,000
3,352,445 shares
31 Dec 2017
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
3.3%
$340,786,000
2,069,005 shares
31 Dec 2017
Bank of New York Mellon Corp
13F
Company
13F
2.6%
$266,930,000
1,620,611 shares
31 Dec 2017
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
243
Shares
47,521,631
Rows available
243
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2018 vs Q4 2025 Across Filers

Q4 2025 holders
2
Q1 2018 holders
243
Holder diff
241
Investor Q4 2025 Shares Q1 2018 Shares Share Diff Share Chg % Q4 2025 value Q1 2018 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .